Personalis Inc
Personalis Inc (PSNL) Implied Volatility Current
PSNL implied volatility is 79%. IV Rank is 13%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking PSNL implied volatility helps you identify when options premiums on Personalis Inc are historically cheap or expensive, and where the best trades are hiding. Personalis Inc implied volatility reflects the market's expectation of future price movement: when PSNL IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Personalis Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PSNL, tracking metrics like PSNL IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PSNL signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities.
The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PSNL implied volatility sits today versus where it has been. Our scanner ranks Personalis Inc implied volatility against its historical range, surfaces extremes in PSNL IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Personalis Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track PSNL IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→